3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Neoplasms
13
Pancreatic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Thyroid Diseases
2
Prostatic Neoplasms
2
Pancreatic Cyst
2
Neoplasm Metastasis
2
Myasthenia Gravis
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Wilms Tumor
1
Venous Thrombosis
1
Venous Thromboembolism
1
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thrombosis
1
Testicular Neoplasms
1
Interventions
Dexamethasone
8
Bortezomib
7
Cyclophosphamide
6
Lenalidomide
4
isatuximab
3
glucarpidase
3
Calcium Dobesilate
3
Thalidomide
2
Kidney Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
pomalidomide
1
gamma-Glutamyl Hydrolase
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
auricularum
1
Whole-Body Irradiation
1
Urination
1
Urinalysis
1
Stents
1
Standard of Care
1
Rituximab
1
Ranitidine
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Methotrexate
1
Leucovorin
1
Ice
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency
×
Data Collection
×
Clear all
NCT03234335
2023-05-06
IRMYG
Centre Hospitalier Universitaire de Saint Etienne
Completed
50 enrolled